For example, hormone-negative breast cancers (e.g. TNBC vs. non-TNBC, ER+ vs. ER-, PR+ vs. PR-) and metastatic prostate cancer have differential RARRES1 gene expression (Fig 4A). Here, RARRES1 is linked to metastatic prostate carcinoma.